Cargando…
Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study
OBJECTIVE: This study aimed to identify possible improvements in disease-specific health-related quality of life (HRQoL) after multiple injections of botulinum toxin A over 24 weeks in Thai cervical dystonia (CD) patients. MATERIALS AND METHODS: A 24-week prospective study comparing HRQoL of Thai CD...
Autores principales: | Kongsaengdao, Subsai, Maneeton, Benchalak, Maneeton, Narong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237598/ https://www.ncbi.nlm.nih.gov/pubmed/28138245 http://dx.doi.org/10.2147/NDT.S116325 |
Ejemplares similares
-
Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study
por: Kongsaengdao, Subsai, et al.
Publicado: (2018) -
The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A
por: Kongsaengdao, Subsai, et al.
Publicado: (2021) -
Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study
por: Kongsaengdao, Subsai, et al.
Publicado: (2021) -
Effectiveness of Favipiravir monotherapy in the treatment of COVID-19: real world data analysis from Thailand
por: Srisubat, Attasit, et al.
Publicado: (2023) -
Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Maneeton, Benchalak, et al.
Publicado: (2022)